Earnings results expected in 18 days
Summary
1ZTS closed today lower at €128.74, a decrease of 1.17% from yesterday's close, completing a monthly decrease of -14.49% or €21.82. Over the past 12 months, 1ZTS stock lost -17.85%.
1ZTS pays dividends to its shareholders, with the most recent payment made on Mar 04, 2025. The next announced payment will be in In 1 month on Jun 03, 2025 for a total of €0.5.
The last earnings report, released on Feb 11, 2025, exceeded the consensus estimates by 0.06%. On average, the company has surpassed earnings expectations by 0.06%, based on the last three reports. The next scheduled earnings report is due on Apr 30, 2025.
The stock of the company had never split.
The company's stock is traded on 13 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track 1ZTS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
1ZTS Chart
Loading, please wait...
Zoetis Inc. (1ZTS) FAQ
What is the stock price today?
The current price is €128.74.
On which exchange is it traded?
Zoetis Inc. is listed on NYSE.
What is its stock symbol?
The ticker symbol is 1ZTS.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Apr 30, 2025.
Has Zoetis Inc. ever had a stock split?
No, there has never been a stock split.
Zoetis Inc. Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Ms. Kristin C. Peck CEO | XMIL Exchange | US98978V1035 ISIN |
| US Country | 14,100 Employees | 21 Apr 2025 Last Dividend | - Last Split | 1 Feb 2013 IPO Date |
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Contact Information
Address: 10 Sylvan Way, Parsippany, NJ, United States, 07054
Phone: 973 822 7000
Website: https://www.zoetis.com
2025 © Marketlog. All Rights Reserved.
